Apoquel 3.6 mg (Oclacitinib (Oclacitinib Maleate) TABLET (CHEWABLE)) 3.6 MG

APOQUEL 3.6 MG chewable tablets contain oclacitinib, a medication used to manage itch and inflammation in dogs. This prescription treatment is designed for oral administration and is manufactured by Zoetis Canada Inc.

Strength

3.6 MG

Manufacturer / TM Owner

ZOETIS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

APOQUEL 3.6 MG is primarily used to control itching and inflammation associated with allergic dermatitis and other skin conditions in dogs. Veterinarians may prescribe oclacitinib for dogs experiencing discomfort due to allergies. This medication is formulated to provide relief from itching, which can help improve the quality of life for affected pets.

Side Effects

Common effects of APOQUEL 3.6 MG may include reduced itching and inflammation in dogs. Some pets may experience mild side effects such as vomiting or diarrhea, although not all dogs will have these effects. It is important to monitor your pet for any unusual symptoms and consult your veterinarian if concerns arise.

Precautions & Warnings

APOQUEL 3.6 MG should be used as directed by a veterinarian. It is important to follow the prescribed dosage and administration instructions. This medication is not suitable for all dogs, particularly those with certain medical conditions or those taking specific medications. Always inform your veterinarian about any other treatments your pet is receiving.

Avoid Interactions

APOQUEL 3.6 MG may interact with other medications, including those that suppress the immune system. It is crucial to discuss all current medications with your veterinarian to avoid potential interactions. Additionally, certain health conditions may affect the safety and effectiveness of oclacitinib, so a thorough health assessment is recommended before starting this treatment.

Frequently Asked Questions

APOQUEL 3.6 MG is used to manage itching and inflammation in dogs, often associated with allergic dermatitis and other skin conditions.

APOQUEL 3.6 MG is a chewable tablet designed for oral administration. Follow your veterinarian's instructions for proper dosage and administration.

Common side effects may include vomiting or diarrhea, although not all dogs will experience these effects. Monitor your pet for any unusual symptoms.

APOQUEL 3.6 MG may interact with other medications, particularly those that suppress the immune system. Consult your veterinarian before combining treatments.

APOQUEL 3.6 MG is not suitable for all dogs, especially those with certain medical conditions. A veterinary assessment is recommended before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.